We are live on ! Find out more
HAIM

Hunter Associates Investment Management Portfolio holdings

AUM $868M
1-Year Est. Return 32.25%
This Fund
S&P 500
This Quarter Est. Return
+7.05%
1 Year Est. Return
+32.25%
3 Year Est. Return
+76.06%
5 Year Est. Return
+90.53%
10 Year Est. Return
+362.12%
AUM
$467M
AUM Growth
+$52M
Cap. Flow
+$31.1M
Cap. Flow %
6.65%
Top 10 Hldgs %
30.15%
Holding
272
New
36
Increased
65
Reduced
111
Closed
11

Sector Composition

Rank Sector Weight
1 Technology 23.45%
2 Healthcare 19.02%
3 Industrials 9.61%
4 Consumer Staples 7.32%
5 Financials 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVGO icon
26
Broadcom
AVGO
$1.98T
$4.49M 0.96%
70,030
+8,760
+14% +$527K
LH icon
27
Labcorp
LH
$26.2B
$4.48M 0.96%
22,722
+176
+0.8% +$36.2K
V icon
28
Visa
V
$671B
$4.38M 0.94%
19,321
-254
-1% -$56.5K
DIS icon
29
Walt Disney
DIS
$178B
$4.24M 0.91%
42,280
-759
-2% -$76.5K
BMY icon
30
Bristol-Myers Squibb
BMY
$130B
$4.06M 0.87%
58,645
+5,914
+11% +$417K
ABBV icon
31
AbbVie
ABBV
$440B
$3.93M 0.84%
24,664
-836
-3% -$128K
APD icon
32
Air Products & Chemicals
APD
$67.7B
$3.93M 0.84%
13,672
-1,103
-7% -$322K
NXPI icon
33
NXP Semiconductors
NXPI
$58.9B
$3.71M 0.79%
19,839
-65
-0.3% -$11.6K
HY icon
34
Hyster-Yale Materials Handling
HY
$614M
$3.49M 0.75%
69,900
+5,150
+8% +$189K
PPG icon
35
PPG Industries
PPG
$25.5B
$3.47M 0.74%
25,955
+227
+0.9% +$29.3K
LLY icon
36
Eli Lilly
LLY
$1.09T
$3.31M 0.71%
9,646
ANSS
37
DELISTED
Ansys
ANSS
$3.27M 0.7%
9,819
-50
-0.5% -$14.1K
IGSB icon
38
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
$3.19M 0.68%
63,061
CVS icon
39
CVS Health
CVS
$121B
$3.12M 0.67%
42,013
+6,697
+19% +$562K
PM icon
40
Philip Morris
PM
$290B
$2.89M 0.62%
29,699
-2,319
-7% -$231K
MCD icon
41
McDonald's
MCD
$195B
$2.88M 0.62%
10,310
-69
-0.7% -$18.5K
ABT icon
42
Abbott
ABT
$192B
$2.83M 0.61%
27,990
-306
-1% -$32.3K
MRK icon
43
Merck
MRK
$328B
$2.77M 0.59%
26,071
-2,072
-7% -$224K
IWR icon
44
iShares Russell Mid-Cap ETF
IWR
$57.9B
$2.71M 0.58%
38,716
+20,711
+115% +$1.46M
COHR icon
45
Coherent
COHR
$69.6B
$2.65M 0.57%
69,927
+4,614
+7% +$188K
SYK icon
46
Stryker
SYK
$133B
$2.59M 0.56%
9,088
GIS icon
47
General Mills
GIS
$20.4B
$2.58M 0.55%
30,105
-134
-0.4% -$10.7K
HOLX
48
DELISTED
Hologic
HOLX
$2.54M 0.54%
31,434
-800
-2% -$64.4K
APTV icon
49
Aptiv
APTV
$10.1B
$2.53M 0.54%
22,587
-50
-0.2% -$5.52K
WSO icon
50
Watsco Inc
WSO
$12.8B
$2.53M 0.54%
7,910
-1,000
-11% -$294K

Similar funds

Hunter Associates Investment Management's Q1 2023 Portfolio in Review

As of Q1 2023, Hunter Associates Investment Management held 272 positions worth $467M, up 13% from $415M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Hunter Associates Investment Management deployed $31.1M of net new capital in Q1 2023, opening 36 new positions and adding to 65 existing holdings. Its largest new stake was Matthews International: 24,256 shares worth $873K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was JPMorgan Inflation Managed Bond ETF, an estimated $1.63M trimmed.

  • Hunter Associates Investment Management's largest Q1 2023 buy was Matthews International: 24,256 shares worth $873K.
  • Hunter Associates Investment Management added most to iShares Core 1-5 Year USD Bond ETF in Q1 2023, an estimated $4.76M increase.
  • Hunter Associates Investment Management's biggest Q1 2023 reduction was JPMorgan Inflation Managed Bond ETF, cutting an estimated $1.63M.
  • Hunter Associates Investment Management fully exited Alico in Q1 2023, selling an estimated $494K.
  • Hunter Associates Investment Management's ten largest holdings make up 30% of its $467M portfolio in Q1 2023.
  • Hunter Associates Investment Management opened 36 new positions and closed 11 in Q1 2023.
  • Hunter Associates Investment Management's portfolio value rose 13% quarter-over-quarter to $467M.

Based on Hunter Associates Investment Management's 13F filing for Q1 2023, filed 2 May 2023.